AAAAAA
Results:
1-10
|
Results: 10
Authors:
GUNTHER C
KECSKES A
STAKS T
TAUBER U
Citation: C. Gunther et al., PERCUTANEOUS-ABSORPTION OF METHYLPREDNISOLONE ACEPONATE FOLLOWING TOPICAL APPLICATION OF ADVANTAN(R) LOTION ON INTACT, INFLAMED AND STRIPPED SKIN OF MALE-VOLUNTEERS, SKIN PHARMACOLOGY AND APPLIED SKIN PHYSIOLOGY, 11(1), 1998, pp. 35-42
Authors:
BOLLOW M
TAUPITZ M
HAMM B
STAKS T
WOLF KJ
WEINMANN HJ
Citation: M. Bollow et al., GADOLINIUM-ETHOXYBENZYL-DTPA AS A HEPATOBILIARY CONTRAST AGENT FOR USE IN MR CHOLANGIOGRAPHY - RESULTS OF AN IN-VIVO PHASE-I CLINICAL-EVALUATION, European radiology, 7(1), 1997, pp. 126-132
Authors:
HAMM B
STAKS T
MUHLER A
BOLLOW M
TAUPITZ M
FRENZEL T
WOLF KJ
WEINMANN HJ
LANGE L
Citation: B. Hamm et al., PHASE-I CLINICAL-EVALUATION OF GD-EOB-DTPA AS A HEPATOBILIARY MR CONTRAST AGENT - SAFETY, PHARMACOKINETICS, AND MR-IMAGING, Radiology, 195(3), 1995, pp. 785-792
Authors:
HAMM B
STAKS T
TAPUITZ M
MAIBAUER R
SPEIDEL A
HUPPERTZ A
FRENZEL T
LAWACZECK R
WOLF KJ
LANGE L
Citation: B. Hamm et al., CONTRAST-ENHANCED MR-IMAGING OF LIVER AND SPLEEN - 1ST EXPERIENCE IN HUMANS WITH A NEW SUPERPARAMAGNETIC IRON-OXIDE, Journal of magnetic resonance imaging, 4(5), 1994, pp. 659-668
Authors:
KRAUSE W
SCHUHMANNGIAMPIERI G
STAKS T
KAUFMANN J
Citation: W. Krause et al., DOES PROPORTIONALITY OF IOPROMIDE PHARMACOKINETICS AND TOLERABILITY AFTER IV INJECTION IN HEALTHY-VOLUNTEERS, European Journal of Clinical Pharmacology, 46(4), 1994, pp. 339-343
Authors:
STAKS T
SCHUHMANNGIAMPIERI G
FRENZEL T
WEINMANN HJ
LANGE L
PLATZEK J
Citation: T. Staks et al., PHARMACOKINETICS, DOSE PROPORTIONALITY, AND TOLERABILITY OF GADOBUTROL AFTER SINGLE INTRAVENOUS-INJECTION IN HEALTHY-VOLUNTEERS, Investigative radiology, 29(7), 1994, pp. 709-715
Authors:
HAMM B
STAKS T
TAUPITZ M
Citation: B. Hamm et al., SHU 555A - A NEW SUPERPARAMAGNETIC IRON-OXIDE CONTRAST AGENT FOR MAGNETIC-RESONANCE-IMAGING, Investigative radiology, 29, 1994, pp. 190000087-190000089
Authors:
KUHNZ W
STAKS T
JUTTING G
Citation: W. Kuhnz et al., PHARMACOKINETICS OF LEVONORGESTREL AND ETHINYLESTRADIOL IN 14 WOMEN DURING 3 MONTHS OF TREATMENT WITH A TRI-STEP COMBINATION ORAL-CONTRACEPTIVE - SERUM-PROTEIN BINDING OF LEVONORGESTREL AND INFLUENCE OF TREATMENT ON FREE AND TOTAL TESTOSTERONE LEVELS IN THE SERUM, Contraception, 50(6), 1994, pp. 563-579
Authors:
KUHNZ W
STAKS T
JUTTING G
Citation: W. Kuhnz et al., PHARMACOKINETICS OF CYPROTERONE-ACETATE AND ETHINYLESTRADIOL IN 15 WOMEN WHO RECEIVED A COMBINATION ORAL-CONTRACEPTIVE DURING 3 TREATMENT CYCLES, Contraception, 48(6), 1993, pp. 557-575
Authors:
KUHNZ W
BAUMANN A
STAKS T
DIBBELT L
KNUPPEN R
JUTTING G
Citation: W. Kuhnz et al., PHARMACOKINETICS OF GESTODENE AND ETHINYLESTRADIOL IN 14 WOMEN DURING3 MONTHS OF TREATMENT WITH A NEW TRI-STEP COMBINATION ORAL-CONTRACEPTIVE - SERUM-PROTEIN BINDING OF GESTODENE AND INFLUENCE OF TREATMENT ONFREE AND TOTAL TESTOSTERONE LEVELS IN THE SERUM, Contraception, 48(4), 1993, pp. 303-322
Risultati:
1-10
|